Ozempic® has become a household name for weight management, but for most people searching for alternatives, the real goal is not another injection. They are trying to solve one of three specific problems: cost is out of reach, the side effects are not worth it, or getting a prescription is not an option.
The answers to those three problems lead to very different places. Prescription switching, cheaper access routes, and natural or over-the-counter options each come with distinct trade-offs. Lumping them together as "Ozempic alternatives" does not help anyone make a real decision.
This guide covers realistic options honestly: pharmaceutical alternatives, compounded semaglutide, and natural supplements, with what the evidence actually shows for each. If cost is the main driver, start with the comparison table below. If you are looking for an option without a prescription, jump ahead to the natural alternatives section.
Affordable Ozempic Alternatives: What Each Option Actually Costs
Cost is the most common reason people start looking for Ozempic alternatives. The list price for branded Ozempic sits above $900 per month without insurance, a figure that puts it out of reach for most people paying out of pocket. The options below range from cheaper prescriptions and compounded versions to natural supplements that cost a fraction of that amount, and every option carries a trade-off worth understanding.
| Alternative | Type | Prescription? | Monthly Cost i Estimated monthly cost without insurance | Key Trade-off |
|---|---|---|---|---|
| Wegovy® injection 2.4 mg (semaglutide) | Prescription GLP-1 mimic | Yes | $349/mo (NovoCare, GoodRx) | FDA-approved for weight loss; same injection/side effect profile as Ozempic |
| Wegovy® pill 25 mg (semaglutide) | Prescription GLP-1 mimic | Yes | $299/mo (NovoCare, GoodRx) | Removes injection but requires careful daily dosing; still prescription-only; comparable trial outcomes to injection; similar side effect profile to Wegovy injection |
| Zepbound® 7.5 mg (tirzepatide) | Prescription GLP-1/GIP mimic | Yes | $449/mo (LillyDirect) | Strongest average weight loss data in class; same injection/access barriers |
| Saxenda® generic 3 mg (liraglutide) | Prescription GLP-1 mimic | Yes | ~$1,165/mo | Daily injection; longest safety record; generic available |
| Compounded semaglutide | Off-label prescription GLP-1 mimic | Yes | ~$179–$400/mo | Cheaper; FDA shortage designation ended Feb 2025; quality not FDA-regulated |
| Berberine | OTC supplement | No | ~$20–$50/mo | No direct human GLP-1 trial evidence; GI side effects common |
| Akkermansia muciniphila | OTC probiotic | No | ~$30–$100/mo | Minor increase in GLP-1 in humans with minimal weight loss |
| Amarasate (Calocurb) | OTC supplement | No | ~$60–$80/mo | Only OTC option with peer-reviewed human clinical data on GLP-1 release and appetite reduction |
Wegovy — Higher-Dose Semaglutide, Approved for Weight Loss
Wegovy contains the same active ingredient as Ozempic (semaglutide) at a higher weekly maintenance dose of 2.4mg. Unlike Ozempic, which is approved for Type 2 diabetes, Wegovy is FDA-approved specifically for chronic weight management in adults and adolescents 12 and older, and for cardiovascular risk reduction in adults with obesity.
The clinical evidence is substantial. The STEP 1 trial showed an average 14.9% reduction in body weight over 68 weeks at the 2.4 mg dose. 1 Wegovy is also available as a daily oral pill. The OASIS 4 trial found a 13.6% average weight loss with the oral formulation, comparable to the injection. 2 The pill removes the injection barrier, but the prescription requirement and cost remain.
On price: As of May 2026, both the Wegovy injection and oral pill carry a list price of $1,349 per month, which is scheduled to reduce to $675 on January 1, 2027.
For out-of-pocket costs, the Wegovy Pen 2.4 mg dose is available for $349 per month via NovoCare or GoodRx, featuring an introductory price of $199 per month for the first two (lower dose) fills and a $399 per month rate for the 7.2 mg dose. The Wegovy Pill has a self-pay price of $299 per month, with a $149 per month introductory rate for the lowest dose.
Under the Medicare GLP-1 Bridge pilot program running from July 1, 2026, through December 31, 2027, certain Medicare recipients can access Wegovy for $50 per month (reflecting a 50% co-pay). Commercial insurance with a savings card can bring costs as low as $25 per month.
For a direct comparison of the oral option and a natural alternative, read our guide on Wegovy pill vs Calocurb: oral semaglutide and a natural GLP-1 approach compared.
Zepbound and Mounjaro® — Tirzepatide and the Strongest Efficacy Data
Tirzepatide works similarly to semaglutide. However, rather than just mimicking natural GLP-1 and activating its receptors, it also mimics another hormone called GIP. It's called a "dual receptor agonist" for that reason. Zepbound is FDA-approved for weight management; Mounjaro is the same compound approved for Type 2 diabetes. Both contain the same active ingredient, but Zepbound is used at higher doses.
The efficacy data is the strongest of the currently FDA-approved GLP-1s. The SURMOUNT-1 trial showed average body weight loss of 20.9% at the highest dose (15mg per week) over 72 weeks. 3 In a direct head-to-head comparison, SURMOUNT-5 showed tirzepatide averaging 20.2% weight loss versus 13.7% for semaglutide over 72 weeks. 4 Tirzepatide also showed lower rates of GI-related discontinuation in that trial, at 2.7% versus 5.6% for semaglutide; injection site reactions were more common with tirzepatide than with semaglutide (32 cases vs 1). 5
Zepbound carries a list price of $1,086 per month. Eli Lilly offers self-pay pricing via LillyDirect at $449 per month for the vial form or KwikPen format (noting that the single-dose prefilled pen costs more). However, regular tiered pricing scales directly by dose: $299 for 2.5 mg, $399 for 5 mg, $499 for 7.5 mg, and $699 for all doses 10 mg and above (10 mg, 12.5 mg, and 15 mg). Commercial insurance with a savings card can drop the price to as low as $25 per month. Additionally, certain Medicare recipients can access Zepbound for $50 per month under the GLP-1 Bridge pilot program starting July 2026. Verify current pricing and eligibility with your prescriber.
Saxenda — Daily Injection With the Longest Safety Record
Saxenda (liraglutide) is the longest-running FDA-approved GLP-1 weight management medication on the market. It uses the same compound as the diabetes drug Victoza® at a higher dose, given as a daily injection rather than weekly.
Average weight loss in trials is more modest than Wegovy or Zepbound. The SCALE Obesity trial showed approximately 8% body weight reduction over 56 weeks. 6 The trade-off is a longer post-market safety record than any other weight-loss GLP-1 in the class.
Saxenda carries a list price of $1,349 per month, and its brand-name self-pay price remains high at ~$1,350 per month. While a standard generic version of liraglutide is available, it costs approximately $1,165 per month, though discount cards may lower it further. With commercial coverage, the price can drop to $25–$60 per month. Saxenda is not included in the Medicare GLP-1 Bridge program. Verify current pricing with your pharmacist.
Rybelsus® — Oral Semaglutide for Diabetes, No Injection Required
Rybelsus is an oral semaglutide tablet (3 mg, 7 mg, 14 mg) approved for Type 2 diabetes management, taken daily first thing in the morning, 30 minutes before food or other medications. It is not approved for weight loss.
It is worth being specific about what Rybelsus is and is not. The available doses are not equivalent to higher Ozempic doses of 1 mg or 2 mg, so it is not a direct substitute for people on Ozempic for weight management. It is a relevant option for needle-averse people managing Type 2 diabetes who want to stay on semaglutide. List price is approximately $968 per month; a manufacturer savings card is available. Rybelsus is not included in the Medicare GLP-1 Bridge program.
Compounded Semaglutide — The Cheapest Prescription Route
Compounded semaglutide became widely available during the 2023 to 2024 branded GLP-1 shortage. Pricing ranged from approximately $179 to $400 per month via telehealth prescription, significantly cheaper than branded alternatives.
The regulatory situation changed in February 2025. The FDA ended the semaglutide shortage designation on February 21, 2025, which restricts when compounding pharmacies are authorized to produce it. Compounded tirzepatide availability is also subject to fluctuating FDA shortage classifications.
If you pursue this route, quality is a material concern. Compounded medications are not subject to the same FDA manufacturing standards as branded drugs, and the FDA has issued adverse event reports linked to compounded GLP-1 products. If you consider this option, choose a PCAB-accredited pharmacy and confirm the prescription through a licensed provider.
Natural Supplements — The Most Affordable Category, With One Stand-Out, Clinically Evidenced Option
Natural supplements require no prescription, making them highly accessible for people who want to avoid the pharmaceutical route entirely, or who want supportive appetite control between, after, or even during a prescription period.
Evidence quality varies significantly across natural supplements. Most have minimal human clinical data on GLP-1 activity, hunger reduction, or caloric intake and show only modest effects. One exception is Calocurb (Amarasate), which is the only natural supplement with peer-reviewed, published human clinical trials specifically on GLP-1 release and appetite reduction. Calocurb requires no prescription and sits at a flat list and self-pay price of $2 per dose, making it significantly more affordable than out-of-pocket brand-name pharmaceuticals. Insurance coverage is not available.
For those still deciding whether to start, switch, or stop GLP-1 medications, you can explore our guide to natural versus injectable weight loss options.
Natural Ozempic Alternatives: What the Evidence Shows — and Why They Cost Less
Natural supplements are cheaper than prescription GLP-1s for structural reasons. There is no FDA drug approval process, no patent protection, no prescription infrastructure. Calocurb at approximately $90 per month reflects that structure. Cheaper, however, is not the same as equivalent, and for natural alternatives, the relevant question is not the price. It is what the evidence actually shows.
Prescription GLP-1 agonists like semaglutide and tirzepatide deliver synthetic hormone mimics at levels far higher and for much longer than natural production. This produces significant weight loss but drives most of the side effect profile. Natural approaches work differently: either stimulating the body's own GLP-1 production through specific biological signals, or claiming metabolic associations without direct evidence for GLP-1 activity in humans.
The relevant question is not "does this claim to boost GLP-1?" but "does it have peer-reviewed, published human clinical evidence showing it affects GLP-1 levels, hunger, or caloric intake?" Most natural supplements in this category fail that test clearly. One does not.
Berberine — What the Evidence Actually Shows
Berberine has been widely called "nature's Ozempic" on social media. That label significantly overstates what the research shows.
The mechanism involves activation of the metabolic pathways that use an enzyme called AMPK, with some association to GLP-1-related activity in animal studies and laboratory research. Human evidence for direct GLP-1 effects is a different matter. In terms of weight loss, one analysis of 12 human trials showed modest but significant reductions in BMI, waist circumference, and weight loss with berberine, 7 while another of 10 trials didn't find any significant reduction in weight. 8 No published clinical trials have specifically measured berberine's effect on GLP-1 release or appetite reduction in humans, which is the relevant comparison for anyone evaluating it as an Ozempic alternative.
Side effects that wellness marketing tends to omit include gastrointestinal symptoms — nausea, cramping, and diarrhea — particularly at higher doses. Berberine also has documented interactions with a range of commonly prescribed medications, including warfarin, cyclosporin A, metformin, ciprofloxacin, ketoconazole, lovastatin, and tamoxifen. 9
Cost is approximately $20 to $50 per month with no prescription required. For a full comparison of berberine alongside other natural weight loss options, see our review of alternatives to Ozempic for weight loss.
Akkermansia — More Hype Than Proof?
Probiotics that contain Akkermansia muciniphila are promoted for appetite control, because these bacteria produce substances that have been shown in mice to increase GLP-1. 10 However, in a study in obese humans, Akkermansia supplementation did not increase GLP-1 levels and produced only slight (insignificant) weight loss. 11
Akkermansia supplementation should be used with caution in certain diseases that affect gut wall integrity, such as inflammatory bowel disease, IBD (or conditions associated with increased risk of IBD, like endometriosis or PCOS/PMOS). 12 High levels of Akkermansia are present in the gut microbiomes of people with Parkinson's disease and multiple sclerosis. Like Berberine, it's also associated with certain drug interactions, including metformin and cancer therapies (cisplatin, paclitaxel, gemcitabine) and with resveratrol. 13
Akkermansia prices vary from around $20/month to over $100/month.
Amarasate — A Natural Option With Direct Clinical Evidence
Amarasate is a standardised bitter hops extract (Humulus lupulus L) developed and grown in New Zealand, with government-funded research and a patented mechanism. It is the active ingredient in Calocurb.
The mechanism is specific. Amarasate activates bitter taste receptors in the gut's enteroendocrine L-cells and I-cells, triggering direct release of GLP-1: the same satiety hormone involved in Ozempic's mechanism, but stimulated locally in the gut rather than delivered systemically via injection. This is distinct from berberine and other metabolic supplements, which do not have evidence for this specific pathway in humans.
Calocurb's clinical evidence comes from three peer-reviewed, published human trials. In a 2022 meal study that measured blood levels of gut hormones after taking Calocurb, GLP-1 was increased by 6.4 times (and other gut hormones that promote fullness also increased significantly) resulting in an 18% reduction in caloric intake at the subsequent meal. 14 A 24-hour, water-only fasting trial in men showed a 20% overall hunger reduction, 15 while a similar trial in women produced even stronger results: a 30% hunger reduction, 40% reduction in food cravings, and 14% fewer calories eaten at the meal following the fast. 16 Effects were measurable within one hour of dosing in trial conditions. 17 18 19
6.4×
Increase in GLP-1 levels observed in a 2022 human meal study (Walker 2022)
18%
Reduction in caloric intake at a subsequent meal (Walker 2022)
20%
Hunger reduction in men during a 24-hour fast (Walker 2019)
30%
Hunger reduction in women during a 24-hour fast (Walker 2024)
No significant adverse effects were reported across the three published trials. Mild gastrointestinal symptoms have been occasionally observed in trial participants, typically resolving without intervention.
At approximately $80 to $90 per month with no prescription required, Amarasate is significantly less expensive than any uninsured prescription GLP-1 option, even with savings cards. Plant-based, non-stimulant, no injection: 1 to 2 capsules taken one hour before eating or before a time when you don't want to eat anything (for example, if you're trying to avoid late-night snacking).
What Amarasate is not: a pharmaceutical-strength GLP-1 agonist. Calocurb does not produce the magnitude of weight loss seen in Wegovy or Zepbound trials and is not designed to. It is the evidence-based option for people who want appetite support and natural weight management without the prescription, injection, and side effect profile of pharmaceutical GLP-1s.
The natural GLP-1 option
Clinically backed appetite support — no prescription needed
Calocurb contains Amarasate®, the only natural supplement with peer-reviewed human trial data on GLP-1 release and appetite reduction. Plant-based, non-stimulant, no injection.
Lifestyle Habits That Support Natural GLP-1 Production
Before any supplement, your daily habits have a measurable effect on your body's own GLP-1 production. These are not alternatives to clinical interventions, but they are real biological inputs, and they cost nothing.
Protein-forward meals: Research suggests that dietary protein is a potent stimulus for GLP-1 release, and consuming protein before carbohydrates at a meal has been associated with a stronger GLP-1 response. 20
Fermentable fiber: Foods like legumes, oats, and resistant starch are fermented by gut bacteria into short-chain fatty acids, which are among the signals that stimulate GLP-1 secretion from intestinal L-cells. 21
Regular exercise: Physical activity — particularly resistance training — has been associated with improved GLP-1 sensitivity and broader metabolic benefits in research settings. 22
Sleep quality: Insufficient or disrupted sleep has been associated with changes in appetite-regulating hormones, including reductions in GLP-1 and elevations in ghrelin, the hunger-stimulating hormone. 23
For a deeper look at each of these strategies, check out our How to Increase GLP-1 Naturally article.
How to Choose the Right GLP-1 Alternative for Your Situation
| Your Situation | Likely Best Fit |
|---|---|
| Want maximum weight loss efficacy, have prescription access | Zepbound or Wegovy with prescriber guidance |
| Ozempic too expensive, open to prescription | Compounded semaglutide via telehealth (verify current FDA status) or Saxenda generic |
| Want GLP-1 benefits without injection, prescription is fine | Wegovy pill or Rybelsus (diabetes indication only) |
| Want no prescription, no injection, clinically backed mechanism | Calocurb (Amarasate) |
| Transitioning off GLP-1 medication, want natural maintenance support | Amarasate alongside diet and lifestyle habits |
| Want to start with lifestyle changes before any supplement | Protein-forward diet, fibre, exercise, sleep, with natural GLP-1 support as an optional complement |
If prescription-strength GLP-1 management is clinically appropriate for you, that decision belongs with your prescriber. Calocurb is not a substitute for people who need pharmaceutical GLP-1 support. However, it can be a useful add-on to prescription GLP-1s, because it may enable your doctor to prescribe them at lower doses (with fewer side effects).
It is, however, the evidence-based option for people who want to avoid the prescription route entirely. Whether you are looking for natural appetite control before starting a pharmaceutical, a cost-effective alternative to continuing on prescription GLP-1s, or clinically backed maintenance support after coming off injectable medications, Calocurb is the only natural option in this category backed by human trial data published in peer-reviewed scientific journals.
